methods and the acid-catalysed cyclisation should provide viable and regiospecific access to many types of
pyrazolidines.
Acknowledgements
We thank Dr Piotr Rutkowski for skilled experimental assistance and advice and the Higher Education
Commission (HEC), Pakistan, for the award of a six month IRSIP fellowship (to FC).
References and notes
1.
2.
On leave from the Institute of Chemistry, University of the Punjab, Lahore, Pakistan.
See, for example, Bhonsle, J. B.; Clark, T.; Bartolotti, L.; Hicks, R. P. Curr. Topics Med. Chem. 2013, 13, 3205-3224;
Wong, C. F.; Bairy, S. Current Pharm. Design 2013, 19, 4739-4754; Teixeira, C.; Serradji, N.; Amroune, S.; Storck, K.;
Rogez-Kreuz, C.; Clayette, P.; Barbault, F.; Maurel, F. J. Mol. Graphics & Modelling 2013, 44, 91-103; Ghemtio, L.;
Perez-Nueno, V. I.; Leroux, V.; Asses, Y.; Souchet, M.; Mavridis, L.; Maigret, B.; Richie, D. W. Comb. Chem. High
Throughput Screening 2012, 15, 749-769; Nichols, S. E.; Swift, R. V.; Amaro, R. E. Curr. Topics Med. Chem. 2012, 12,
2002-2012; Perez-Riverol, Y.; Vera, R.; Mazola, Y.; Musacchio, A. Curr. Topics Med. Chem. 2012, 12, 1790-1796. For a
discussion of modern tactics in drug discovery, see Lee, J. A.; Uhlik, M. T.; Moxham, C. M.; Tomandl, D.; Sall, D. J. J.
Med. Chem. 2012, 55, 4527-4538; Gomtsyan, A. Chem. Het. Cmpds. 2012, 48, 7-10. For a discussion of the relevance of
incorporating more 3D shape to potential pharmaceuticals, see Lovering, F.; Bikker, J.; Humblet, C. J. Med. Chem. 2009,
52, 6752-6756.
3.
4.
Yet, L. Comp. Heterocycl. Chem. III, Katritzky, A. R.; Ramsden, C. A.; Scriven, E. F. V.; Taylor, R. J. K. Eds., Elsevier,
Oxford, 2008, 4.01, 1-141 and references therein.
For recent contributions, see Yang, Q.; Jiang, X.; Ma, S. Chem. Eur. J. 2007, 13, 9310-9316; Alex, K.; Tillack, A.;
Schwarz, N.; Beller, M. Org. Lett. 2008, 10, 2377-2379; Giampietro, N. C.; Wolfe, J. P. J. Am. Chem. Soc. 2008, 130,
12907-12911; Lebedev, O.; Bredihhin, A.; Tšupova, S.; Mäeorg, U. Tetrahedron, 2009, 65, 5438-5442; Voss, E.; Arrault,
A.; Bodiguel, J.; Jamart-Gregoire, B. Tetrahedron: Asymm. 2009, 20, 1809-1812; LaLonde, R. L.; Wang, Z. J.; Mba, M.;
Lackner, A. D.; Toste, F. D. Angew. Chem. Int. Ed. 2010, 49, 598-601; Okitsu, T.; Sato, K.; Wada, A. Org. Lett. 2010, 12,
3506-3509; Jacob, F.; Herdtweck, E.; Bach, T. Chem. Eur. J. 2010, 16, 7537-7546; Kumar, B. S.;
Venkataramasubramanian, V.; Sudalai, A. Org. Lett. 2012, 14, 2468-2471; Yamamoto, Y.; New J. Chem. 2013, 37, 3873;
Chand, S. S.; Prakash, P.; Szymoniak, J.; Preethanuj, P.; Dhanya, B. P.; Radhakrishnan, K. V. Org. Lett. 2013, 15, 3338-
3341 and references therein. For a review of pyrazolidine synthesis and applications, see Davis, L. O. Org. Prep. Proced.
Int. 2013, 45, 437-464
5.
6.
Davis, L. O.; Daniel, W. F. M.; Tobey, S. L. Tetrahedron Lett. 2012, 53, 522-525.
Griffiths-Jones, C. M.; Knight, D. W. Tetrahedron, 2010, 66, 4150-4166; Griffiths-Jones, C. M.; Knight, D. W.
Tetrahedron, 2011, 67, 8515-8528.
7.
8.
For reviews, see: Mitsunobu, O. Synthesis, 1981, 1–28; Hughes, D. L. Org. React. 1992, 42, 335–656; Swamy, K. C. K.;
Kumar, N. N. B.; Balaraman, E.; Pavan Kumar, K. V. P. Chem. Rev. 2009, 109, 2551–2651
Brosse, N.; Pinto, M.-F.; Jamart-Grégoire, B. J. Org. Chem. 2000, 65, 4370-4374; Lebold, T. P.; Kerr, M. A. Org. Lett.
2009, 11, 4354-4357.